Proceeds to drive development of ONP-002, the Company’s lead intranasal drug candidate for mild traumatic brain injurySARASOTA, Fla., July 02, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a clinical-stage biotechnology company pioneering intranasal therapeutics for neurological disorders, today announced the successful closing of its previously announced public offering of Series H Convertible Preferred Stock and Warrants. The Company secured total gross proceeds of approximately $16.5 mi ...

FONAR Board of Directors Appoints Independent DirectorJuly 02, 2025 4:10 PM EDT | Source: Fonar CorporationMelville, New York--(Newsfile Corp. - July 2, 2025) - FONAR Corporation (NASDAQ: FONR), The Inventor of MR Scanning, today announced that on July 2, 2025, its board of directors appointed Mr. Robert M. Carrino as an independent director of the Company's board of directors. This appointment fills a vacancy on the board left by Ms. Claudette J.V. Chan, who recently retired from her position ...

WESTPORT, Conn., July 02, 2025 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE: CODI) (“CODI” or the “Company”), an owner of leading middle market businesses, announced today that its Board of Directors (the “Board”) has declared a quarterly cash distribution for each of its three preferred share series. This announcement underscores that in the wake of its ongoing investigation of Lugano, the Company’s diversified business model supports its continued ability to generate strong cash flow. The Board declared ...

ATHENS, Greece, July 02, 2025 (GLOBE NEWSWIRE) -- Euroseas Ltd. (NASDAQ: ESEA), an owner and operator of container carrier vessels and provider of seaborne transportation for containerized cargoes, announced today that its Board of Directors has called an annual meeting of the shareholders to be held on July 23, 2025, at 11:00 a.m. at the offices of Seward & Kissel LLP, located at 901 K Street NW, Suite 800, Washington, DC 20001. Shareholders of record at the close of business on June 25, 2025, are entitled ...

Acclarent AERA® Eustachian Tube Balloon Dilation System First Patient Enrolled in Acclarent AERA® Pediatric Registry PRINCETON, N.J., July 02, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq: IART), a leading global medical technology company, is proud to announce enrollment of the first patient in the Acclarent AERA Pediatric Registry, a prospective, multi-center observational registry evaluating the real-world use of the AERA Eustachian Tube Balloon Dilation System in childre ...

公司诉讼事件 - Sarepta Therapeutics公司面临集体诉讼 指控其在2023年6月22日至2025年6月24日期间发布重大虚假或误导性声明 [3] - 诉讼涉及基因疗法ELEVIDYS的安全性问题 包括未披露患者重大安全风险及试验方案缺陷 [3] - 公司被指隐瞒ELEVIDYS严重不良反应 导致试验招募暂停并引发监管审查风险 [3] 法律程序进展 - 股东参与集体诉讼的截止日期为2025年8月25日 需通过指定链接登记 [4] - 登记股东将获得案件生命周期内的状态更新 无需承担参与成本 [4] - 牵头原告申请截止日期同为2025年8月25日 但非强制参与条件 [1][4] 涉事产品影响 - ELEVIDYS作为治疗杜氏肌营养不良的基因疗法 其现有及扩展批准风险因安全性问题加剧 [3] - 不良反应严重程度直接影响公司临床试验进程 包括暂停给药等操作 [3]

公司诉讼事件 - Fortrea Holdings Inc (NASDAQ: FTRE) 面临集体诉讼 涉及2023年7月3日至2025年2月28日期间购买股票的股东 [3] - 诉讼指控公司在上述期间发布 materially false and/or misleading statements [3] - 公司被指控高估长期项目(Pre-Spin Projects)对2025年收益的贡献 [3] - 公司被指控夸大退出过渡服务协议可能实现的成本节约 [3] - 公司2025年EBITDA目标被指夸大 [3] - 公司分拆后商业模式及业务/财务前景的可行性被指高估 [3] 诉讼时间节点 - 股东需在2025年8月1日前登记参与集体诉讼 [4] - 股东登记后将获得案件进展监控服务 [4] - 申请成为首席原告的截止日期为2025年8月1日 [4] 律师事务所信息 - The Gross Law Firm 负责此集体诉讼案件 [5] - 该律所专注于保护因欺骗、欺诈和非法商业行为受损的投资者权益 [5] - 律所致力于确保企业遵守负责任的商业实践和良好企业公民行为 [5]

Rocket Lab Corporation (NASDAQ: RKLB ) stock has been flying, up 91% since I initiated my coverage back in mid-March. The success rate for its rocket launches in 2025 has been at 100%, and that's not to mentionI’m a retired Wall Street PM specializing in TMT; since kickstarting my career, I’ve spent over two decades in the market navigating the technology landscape, focusing on risk mitigation through the dot com bubble, credit default of ‘08, and, more recently, with the AI boom. In one word, what I’d like ...

LONDON, July 02, 2025 (GLOBE NEWSWIRE) --  NE10 Vodka Limited, (“NE10”) and/or (the” Company”) a leading international drinks business with a strong emphasis on the production and distribution of premium flavored vodka and ready-to-drink cans, today announced the appointment of two seasoned Directors, further strengthening the Company’s executive leadership team. With immediate effect, Scott Ryder and Simon Young will take their positions as National Sales and Commercial Directors respectively. Scott brings ...

股价表现 - 天然气巨头EQT当前股价上涨0.3%至55.87美元，但仍未从6月23日创下的61.02美元历史峰值回调中完全恢复 [1] - 股价在55美元水平获得支撑，该位置此前为阻力位，且下方存在历史看涨趋势线 [1] - 公司股价年内累计上涨22%，可能迎来新一轮上涨 [1] 技术分析 - EQT当前处于50日均线一个标准差范围内，过去10个交易日中有8天高于该均线，过去两个月80%时间位于均线上方 [2] - 过去五年出现类似技术信号共12次，其中67%概率在一个月后股价上涨，平均涨幅达5.5% [2] - 若实现同等幅度上涨，股价将重返60美元附近，接近历史高点 [2] 期权交易机会 - EQT的Schaeffer波动率指数(SVI)为34%，处于年度区间的第12百分位，显示期权市场对波动率预期较低 [3]